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Caspases are well known proteases in the context of inflammation and apoptosis.
Recently, novel roles of pro-apoptotic caspases have been reported, including findings
related to the development of hard tissues. To further investigate these emerging
functions of pro-apoptotic caspases, the in vivo localisation of key pro-apoptotic
caspases (-3,-6,-7,-8, and -9) was assessed, concentrating on the development
of two neighbouring hard tissues, cells participating in odontogenesis (represented
by the first mouse molar) and intramembranous osteogenesis (mandibular/alveolar
bone). The expression of the different caspases within the developing tissues was
correlated with the apoptotic status of the cells, to produce a picture of whether
different caspases have potentially distinct, or overlapping non-apoptotic functions.
The in vivo investigation was additionally supported by examination of caspases in an
osteoblast-like cell line in vitro. Caspases-3,-7, and -9 were activated in apoptotic cells
of the primary enamel knot of the first molar; however, caspase-7 and -8 activation
was also associated with the non-apoptotic enamel epithelium at the same stage and
later with differentiating/differentiated odontoblasts and ameloblasts. In the adjacent
bone, active caspases-7 and -8 were present abundantly in the prenatal period,
while the appearance of caspases-3,-6, and -9 was marginal. Perinatally, caspases-
3 and -7 were evident in some osteoclasts and osteoblastic cells, and caspase-8
was abundant mostly in osteoclasts. In addition, postnatal activation of caspases-7
and -8 was retained in osteocytes. The results provide a comprehensive temporo-
spatial pattern of pro-apoptotic caspase activation, and demonstrate both unique and
overlapping activation in non-apoptotic cells during development of the molar tooth
and mandibular/alveolar bone. The importance of caspases in osteogenic pathways
is highlighted by caspase inhibition in osteoblast-like cells, which led to a significant
decrease in osteocalcin expression, supporting a role in hard tissue cell differentiation.
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INTRODUCTION
Tooth development proceeds via stages referred to as
placode, bud, cap, and bell (Tucker and Sharpe, 2004),
and is completed by differentiation of two main cell types,
mesenchymal-derived odontoblasts producing dentin and
epithelial-derived ameloblasts secreting enamel (e.g. Lesot et al.,
2014). Odontogenesis is closely related to the development of
other jaw structures including the bone (Diekwisch, 2002; Diep
et al., 2009), which forms by intramembranous ossification
involving direct differentiation of osteoblasts from mesenchymal
precursors (Alfaqeeh et al., 2013).
Caspases are cysteine-dependent aspartate proteases (Cohen,
1997) produced as non-active zymogens (procaspases) and
activated by homodimerisation or cleavage (reviewed in
Boatright and Salvesen, 2003). Pro-apoptotic caspases are
classified as initiators (in mouse these include caspases-
2,-8, and -9) or executors (caspases-3,-6, and -7). These
caspases are engaged in both major pathways of apoptosis;
extrinsic (receptor mediated) and intrinsic (mitochondrial).
The initiators possess a long prodomain, the prodomain of
executors is short (reviewed in Nicholson, 1999). Caspases-3
and -7, although structurally/functionally related, differ in
their N-terminal peptides, regions thought to be involved in
subcellular targeting. Caspase-6 substrate specificity differs
substantially from that of caspases-3 and -7, suggesting a
non-overlapping subset of substrates (reviewed in Fuentes-
Prior and Salvesen, 2004). Beyond pro-apoptotic caspases,
inflammatory caspases (caspases-1, -11, and -12) have been
identified in the mouse along with two additional caspases
(caspases-14 and -16), which do not fit in either category
(reviewed in Shalini et al., 2015). This investigation focused on
the pro-apoptotic caspases with the exception of caspase-2, the
position of which in the apoptotic pathway is unclear (Fava et al.,
2012).
Some of the pro-apoptotic caspases have also been recently
described in non-apoptotic events, such as cell proliferation,
differentiation, migration, regeneration, or senescence (reviewed
in Schwerk and Schulze-Osthoff, 2003; Lamkanfi et al., 2007;
Connolly et al., 2014; Shalini et al., 2015), and ongoing
research indicates novel, non-apoptotic functions of pro-
apoptotic caspases during tooth and bone development.
Roles of pro-apoptotic caspases during tooth development
have typically been classified as apoptotic, particularly in
elimination of signalling centres or reduction of ameloblasts,
odontoblasts, and osteogenic populations (reviewed in Matalova
et al., 2012a). However, non-apoptotic appearance of caspase-
7 was also detected in differentiating/differentiated odontoblasts
and ameloblasts (Matalova et al., 2012b, 2013).
Related to osteogenesis, caspases have been described to
regulate a number of osteogenic cells by apoptotic machinery
(reviewed in Hock et al., 2001). Among non-apoptotic functions,
caspases-3 and -8 were suggested to play a role in osteoblastic
(Mogi and Togari, 2003) and/or osteoclastic differentiation
Abbreviations: E, embryonic day; P, postnatal day; PEK, primary enamel knot.
(Szymczyk et al., 2006; Katao et al., 2013, 2014). Further, caspase-
3 deficient mice show decreased total bone mineral density plus
decreased osteogenic and proliferating capacity of bone marrow
stromal stem cells (BMSSCs) (Miura et al., 2004). A similar
tendency was earlier reported in caspase-7 deficient mice, where
downregulated expression of two important osteogenic factors,
Smad1 andMsx1, was demonstrated (Svandova et al., 2014).
This study was designed to provide a comprehensive
temporo-spatial analysis of activation of the key pro-apoptotic
caspases (-3,-6,-7,-8, and -9) during development of the mouse
molar tooth and surrounding bone, and to investigate non-
apoptotic appearance of these caspases related to the emerging
evidence about their novel roles. Additionally, the novel
potential of caspases was analysed in vitro based on osteocalcin
expression modulation in an osteoblastic cell line derived from
intramembranous bone.
MATERIALS AND METHODS
Biological Material
Mouse heads (ICR/CD1) at embryonic (E) stages E13, E15,
E18, postnatal (P) day P0 and P22 were used for in
situ detection of activated caspases by immunofluorescence,
histological staining, TRAP, and TUNEL analysis. Collected
samples were fixed in 4% buffered paraformaldehyde for at
least 24 h, then dehydrated in an ethanol gradient, treated
with xylene, and embedded in paraffin. Mice were sacrificed
according to the experimental protocol approved by the
Laboratory Animal Science Committee of the UVPS, Brno, Czech
Republic.
A cell line of osteoblastic precursors, MC3T3-E1, was
purchased from the European Collection of Cell Culture (c.n.
99072810) and differentiated for 21 days to allow for the
differentiation of osteoblasts according to Yazid et al. (2010).
Medium consisted of MEM Alpha (Gibco, USA) enriched
by FCS (10%), penicillin/streptomycin (100 U/ml, 100µg/ml),
β-glycerolphosphate (10mM), and ascorbic acid (50µg/ml).
Medium was changed every second day. Passages 12–20 were
used for the experiments.
Histological Staining
Histological sections of heads were stained using trichrome
staining (alcian blue, haematoxylin, and sirius red) and
haematoxylin-eosin staining.
Immunofluorescence
Histological sections were treated with xylene, rehydrated
through a graded ethanol series, and pre-treated in citrate
buffer (pH = 6.0) 10min at 98◦C. The primary antibodies:
cleaved caspase-3 (9664, Cell Signaling, USA), cleaved caspase-6
(9761, Cell Signaling, USA), cleaved caspase-7 (9491S, Cell
Signaling, USA), cleaved caspase-8 (8592, Cell Signaling,
USA), cleaved caspase-9 (9509, Cell Signaling, USA), and
osteocalcin (ab93876, Abcam, UK), were diluted (anti-
caspase-3: 1:50, anti-caspase-6: 1:50, anti-caspase-7: 1:50,
anti-caspase-8: 1:200, anti-caspase-9: 1:50, anti-osteocalcin
1:100) and applied overnight at 4◦C. Alexa Fluor R© 488
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(A11034, Thermo Fischer, USA) or Alexa Fluor R© 594 (A11037,
Thermo Fischer, USA) were diluted 1:200 and then applied
for 40min at room temperature (RT). Nuclei were visualised
by ProLong Gold Antifade reagent with DAPI (Thermo
Fischer, USA).
Immunocytofluorescence
MC3T3-E1 cells were cultured on histologic slides, fixed in 10%
PFA, washed in PBS, and treated with 0.1% Triton X-100 for
15min. The caspase primary antibodies and osteocalcin primary
antibody were diluted as described above; all primary antibodies
were applied overnight at 4◦C. Alexa Fluor R© 488 (A11034,
Thermo Fischer, USA) was diluted 1:200 and then applied for
40min at RT. Nuclei were visualised by ProLong Gold Antifade
reagent with DAPI (Thermo Fischer, USA).
Immunohistochemistry
Histological sections were rehydrated and pre-treated in citrate
buffer as described above. Endogenous peroxidase activity was
eliminated by 3% hydrogen peroxide in PBS (5min at RT).
The primary antibodies were diluted as described above and
applied overnight at 4◦C, peroxidase-conjugated streptavidin-
biotin system (Vectastain, USA) and chromogen substrate
diaminobenzidine (DAB, K3466, Dako, Denmark) reactions
were used to visualise positive cells as brown. Tissues were
counterstained with haematoxylin.
Detection of Osteoclasts - TRAP
Histological sections were rehydrated as described above and
incubated 1 h at 37◦C in a solution consisting of 0.0023M
Naphthol AS-TR phosphate disodium salt (N6125, Sigma
Aldrich, Germany), 0.2M glacial acetic acid, 0.2M sodium
acetate, 0.1M sodium tartrate dibasic dihydrate (S-8640, Sigma
Aldrich, Germany), and 0.5% N-N-dimethylformamide. Tissues
were counterstained with haematoxylin.
TUNEL Assay
Slides were rehydrated as described above. Tissues were pre-
treated with proteinase K 20 mg/ml (15min at RT). Endogenous
peroxidase was blocked with 3% hydrogen peroxide in PBS
(5min at RT). The reaction mixture (TUNEL, S7100, Merck
Millipore, USA) was prepared as follows: 3 µl TdT enzyme,
42 µl distilled water, 105 µl reaction buffer, which was
incubated for 45min at 37◦C. An anti-digoxigenin-peroxidase
reaction was performed for 30min at RT. Positive cells were
finally visualised by the chromogenic substrate diaminobenzidine
(DAB, K3468, Dako, Denmark). Samples were counterstained
with haematoxylin.
Caspase Inhibition in MC3T3-E1 Cells
General caspase inhibitor Z-VAD-FMK (FMK001, R&D Systems,
Germany) was dissolved in DMSO, and applied at a final
concentration of 100µM. The medium was changed every
second day. The control group was treated with the same
concentration of DMSO as used for the experimental samples
to exclude any side effect of this solvent. Cells were seeded
at a concentration of 5000 cells/cm2 and harvested after 5
or 6 days of caspase inhibition. Cells were then lysed in
RLT buffer and used for RNA isolation using the RNeasy
Mini Kit (Qiagen, USA). First strand cDNA was transcribed
using Super Script VILO (Invitrogen, USA). Inhibition of
central caspase-3 at the protein level was verified using a
bioluminescence approach as described earlier (Ledvina et al.,
2017).
qPCR
qPCR was performed in 10 µl final reaction volumes containing
the one-step master mix gb Ideal PCR Master Mix (Generi
Biotech, Czech Republic), qPCR was performed by a LightCycler
96 (Roche, Switzerland) with preheating at 95◦C for 10min,
followed by 40 cycles of 95◦C for 15 s and 62◦C for 1min.
Osteocalcin expression levels (Mouse Bglap, Mm03413826_mH,
TaqMan Gene Expression Assay, Thermo Fischer, USA) were
calculated using the 11CT method, with normalisation against
actin levels (Mouse Actb, Mm02619580_g1, TaqMan Gene
Expression Assay, Thermo Fischer, USA), which was used as the
internal control. For both groups, analysis was performed in three
biological replicates, reactions were performed in triplicates for
each sample. Statistical analysis was performed for both groups
(t-test, p ≤ 0.05).
RESULTS
Development of Tooth and Surrounding
Bone
The mouse first lower molar is frequently used to study
odontogenesis and related osteogenesis, (Cohn, 1957; Gaunt,
1966; Peterková et al., 1996); therefore, we concentrated on
this region for our study. Two stages were studied for the
primary comparative analysis. At E15, the first molar has
reached the early bell stage and the epithelial part can be
distinguished into inner and outer epithelium surrounded by
the dental follicle containing undifferentiated mesenchymal cells
(Figure 1A). Apoptotic elimination of the primary enamel knot
(PEK) was apparent at this stage (Figure 1B; Jernvall et al.,
1998). Later, at P0 (Figure 4A), differentiation of odontoblasts
and ameloblasts proceeded and secretion of dentin was evident
(Figure 4B).
Alveolar bone was already apparent at E15, surrounding
the molar tooth germ and forming a functional component
with the mandibular bone (Figures 2A, 3A). This stage
is characterised by the first appearance of complete
bone (osteoblasts, osteocytes, and osteoclasts). Activated
osteoclasts appeared at this stage to start continuous
dynamic remodelling of the bone (Figures 3D,J). At P0,
the mandibular/alveolar bone completely surrounded the
developing molar (Figure 5A).
Activation of Caspases in the First Molar
Tooth Germ at E15
This stage of odontogenesis is characterised by high levels
of apoptosis (Figure 1B) in the PEK. Activated caspase-
3 (Figure 1C), caspase-7 (Figure 1E), and caspase-9
(Figure 1G) were detected and associated with the PEK
region (Figures 1H–J). Activation of caspase-6 (Figure 1D)
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FIGURE 1 | Activation of caspases in the first mandibular molar at E15. Molar morphology (early bell stage) visualised by haematoxylin-eosin staining (A), apoptotic
cells (brown) labelled by TUNEL assay (B), immunofluorescent detection (green) of caspase-3 (C,H), caspase-6 (D), caspase-7 (E,I), caspase-8 (F), caspase-9 (G,J).
Nuclei were counterstained by DAPI (blue). Ep (epithelium), mb (mandibular bone), mes (mesenchyme), primary enamel knot (PEK). Arrows point to positive cells.
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FIGURE 2 | Activation of caspases in the mandibular/alveolar bone at E15. Mandibular/alveolar bone morphology visualised by trichrome staining (A), apoptotic cells
(brown) labelled by TUNEL assay (B), immunofluorescent detection (green) of caspase-3 (C), caspase-6 (D), caspase-7 (E,H), caspase-8 (F,I), caspase-9 (G). Nuclei
were counterstained by DAPI (blue). Mb (mandibular bone), mc (Meckel’s cartilage). Arrows point to positive cells.
was not observed at this stage of odontogenesis. Caspase-7
and caspase-8 were both apparent in the enamel epithelium
(Figures 1E,F), where apoptotic cells were not found. Activated
caspases in the PEK showed nuclear localisation (Figures 1H–J),
while activated caspases in other parts of the enamel organ were
cytoplasmic (Figures 1E,F).
Frontiers in Physiology | www.frontiersin.org 5 March 2018 | Volume 9 | Article 174
Svandova et al. Caspases in Tooth and Bone Formation
FIGURE 3 | Activation of caspases correlated with osteoclast distribution detected by TRAP in serial sections of the alveolar/mandibular bone at E15.
Haematoxylin-eosin staining (A), activated caspase-3 (B), activated caspase-6 (C), osteoclast detection (D,J), activation of caspase-7 (H), activation of caspase-8 (I)
localised in apoptotic bodies (E), non-apoptotic osteoclast (F), non-apoptotic osteoblasts (G). M1 (first molar), mb (mandibular bone), mc (Meckel’s cartilage). Black
arrows point to intact cells, red arrows point to apoptotic cells.
Activation of Caspases in
Mandibular/Alveolar Bone at E15
Apoptotic cells were already detected in the area of the bone
at E15 (Figure 2B). Only sporadic activation of caspase-3
was apparent in osteoblasts and osteoclasts (Figures 2C, 3B).
Activation of caspase-6 was present in some osteoblasts and
osteoclasts, which were mostly non-apoptotic (Figures 2D, 3C).
Activation of caspase-7 and -8 was abundant at this stage, it was
apparent in osteoblasts as well as osteoclasts (Figures 2E,F,H,I,
3H,I). However, no caspase-9 activation was observed
(Figure 2G).
Some bone cells with activated caspases-3,-7, or -8 showed
apoptotic features, these apoptotic cells exhibited nuclear
localisation of caspases (e.g. Figure 3E). The majority of
osteoblasts (Figure 3G) and osteoclasts (Figure 3F) with
activated caspases-6,-7, and -8 were not apoptotic and showed
cytoplasmic localisation (Figures 3C,H,I).
Activation of Caspases in First Molar
Development at P0
Only sporadic apoptotic cells were found in the tooth germ
(Figure 4C). Caspase-3 (Figure 4D), caspase-6 (Figure 4E),
and caspase-9 (Figure 4H) were not apparent in the tooth at
this stage. Activated caspase-7 was present in pre-odontoblasts/
odontoblasts, pre-ameloblasts/ameloblasts, and some cells
of the dental pulp (Figure 4F). Activation of caspase-
7 displayed a gradient with the strongest signal in the
coronal part of the tooth germ, thus positively correlating
with the gradient of differentiation. Caspase-8 showed a
similar pattern to caspase-7, with additional activation in
the stellate reticulum (Figures 4G,I). In all of these cell
types, activation of caspases-7 and -8 was not linked with
TUNEL-positive cells and activation showed cytoplasmic
localisation.
Activation of Caspases in
Mandibular/Alveolar Bone at P0
A relatively high level of apoptosis was observed in the
remodelling bone under the tooth, where the roots will start
to develop (Figure 5B). High levels of activated caspases
were found in this area. Caspase-3 was activated in few
osteoblasts and some osteoclasts, as identified by multinucleated
morphology of osteoclasts (Figure 5C). Low activation of
caspase-6 was observed in osteoclasts and sporadically in
osteoblasts (Figures 5D,H). Caspase-7 activation was apparent
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FIGURE 4 | Activation of caspases in the first mandibular molar at P0. Molar morphology (differentiation/matrix secretion) visualised by haematoxylin-eosin staining
(A), dentin (black arrow) formation stained by trichrome (B), apoptotic cells labelled by TUNEL assay (C), immunofluorescent detection (green) of caspase-3 (D),
caspase-6 (E), caspase-7 (F), caspase-8 (G,I), caspase-9 (H). Nuclei were counterstained by DAPI (blue). Alv (alveolus), am (ameloblasts), dp (dental pulp), mb
(mandibular bone), od (odontoblasts), sr (stellate reticulum). Arrows point to positive cells.
in both osteoblasts and osteoclasts (Figure 5E). Caspase-8
was present in some osteoblasts and abundantly activated in
osteoclasts (Figures 5F,I). Some of the cells with activated
caspases showed apoptotic morphology but the majority did not,
and in those cases their expression was cytoplasmic. Very low
activation of caspase-9 was observed in osteoclasts at this stage
(Figure 5G). The presence of active caspases in different cell types
at different stages is summarised in Table 1 and documented in
detail in Figures S1, S2. The selection of developmental stages in
order to investigate different stages of odontoblast differentiation
was based on earlier published data (reviewed in Lisi et al.,
2003).
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FIGURE 5 | Activation of caspases in the mandibular/alveolar bone at P0. Bone morphology visualised by trichrome staining (A), apoptotic cells (brown) labelled by
TUNEL assay (B), immunofluorescent detection (green) of caspase-3 (C), caspase-6 (D,H), caspase-7 (E), caspase-8 (F,I), caspase-9 (G). Nuclei were counterstained
by DAPI (blue). Alv (alveolus), M1 (first molar), mb (mandibular bone). White arrows point to positive osteoclasts, yellow arrows point to positive osteoblasts.
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Activation of Caspases in an Osteoblastic
Cell Line
The high level of cytoplasmic caspase expression shown in the
developing mandibular/alveolar bone was then compared to
expression in a bone cell line. For this, the osteoblastic MC3T3-
E1 cell line was chosen as this line is derived, like alveolar bone,
from cells that form bone via intramembranous ossification. Cells
were stimulated using a standard osteogenic medium for 3 weeks
to allow differentiation of bone cells (Yazid et al., 2010). After
culture, the cells showed activation of all caspases under study
(Figures 6A–E) as well as expression of osteocalcin, an important
marker of osteoblastic differentiation (Figure 6F). In agreement
with the in vivo data, predominantly cytoplasmic localisation was
observed in all cases.
Caspase Inhibition in an Osteoblastic Cell
Line
To study the role of caspases during osteoblast differentiation,
a general caspase inhibitor was applied to cultured MC3T3-E1
cells for up to 6 days. The treated cells appeared normal over this
culture period, reaching confluence at the same stage as controls.
Having established that osteocalcin is expressed at high levels
in control cultures, we concentrated on expression of this key
gene. A statistically significant decrease in osteocalcin expression
(Figures 6G,H) was observed after 5 days of inhibition compared
to control, DMSO treated cultures (decrease to 74%, p =
0.01203). A more pronounced decrease was noted at 6 days
(decrease to 46%, p = 0.00263). The loss of osteocalcin RNA
was confirmed by loss of osteocalcin protein in cell culture by
immunofluorescence (Figures 6I,J).
DISCUSSION
In this investigation, a comprehensive analysis of pro-apoptotic
caspase activation in the developing tooth and bone was
provided. The results further highlight important roles for
caspases during odontogenesis and osteogenesis, not only in
apoptosis but also in non-apoptotic processes and suggest both
unique and overlapping functions of the different caspases.
At the late cap stage, the primary enamel knot (PEK)
is apoptotically eliminated (Vaahtokari et al., 1996; Jernvall
et al., 1998; Shigemura et al., 2001) and osteoclasts are first
observed lining the forming alveolar bone, which will gradually
encapsulate the tooth (Alfaqeeh et al., 2013). The initiator caspase
of the intrinsic pathway, caspase-9, has previously been reported
to be essential for apoptosis in the PEK (Setkova et al., 2007), and
caspase-9 deficiency was shown to result in reduced apoptosis
(Kuida et al., 1998). In contrast, caspase-8 was not observed in
this structure, supporting that cell death in this structure is driven
via the intrinsic pathway. Of the executioner caspases, caspase-
3 activation was detected in apoptotic cells of the molar PEK
at this stage (Matalova et al., 2006), and was not observed in
the tooth at later stages, suggesting that the role of caspase-3 in
the tooth is limited to removal of the PEK. Activated caspase-
7 was also present in apoptotic cells of the PEK, but it had
a much wider expression in the tooth compared to caspase-3,
TABLE 1 | Summarising table of observed activation of apoptotic caspases.
Caspase-3 Caspase-6 Caspase-7 Caspase-8 Caspase-9
Primary
enamel knot
*** – *** – ***
Enamel
epithelium
– – ** * –
Pre-
/ameloblasts
– – ** * –
Stellate
reticulum
– – – *** –
Dental
mesenchyme
– – – – –
Pre-
/odontoblasts
– – ** ** –
Pre-
osteoblasts
– – – * *
Osteoblasts
(prenatal)
* * ** ** –
Osteoblasts
(postnatal)
* – *** * –
Osteocytes * – ** * –
Lining cells – – * ** –
Osteoclasts
(prenatal)
* * ** *** –
Osteoclasts
(postnatal)
* * *** *** *
− negative; * weak activation; ** medium activation; *** abundant activation.
being expressed in other parts of the dental epithelium at the
cap stage and in odontoblasts and ameloblasts at later stages.
The more widespread expression of caspase-7, in contrast to
caspase-3, supports the previous suggestion that the functions
of caspases-3 and -7 are partially distinct and may not act
redundantly (Chandler et al., 1998; Walsh et al., 2008; Nakatsumi
and Yonehara, 2010). The last of the executioner trio of caspases,
caspase-6, had not previously been investigated in odontogenesis
and osteogenesis. In our study, activation of caspase-6 did not
occur within the tooth germ, and, therefore, does not function in
PEK removal. Activation of caspases-3, -7, and -9 was localised to
the nucleus of the PEK cells, agreeing with previous suggestions
that nuclear localisation is associated with apoptotic roles (Faleiro
and Lazebnik, 2000; Fischer et al., 2003; Kamada et al., 2005).
Later in tooth development, caspase-8 and caspase-7 were
identified in differentiating/differentiated odontoblasts and
ameloblasts as well as cells of dental pulp within the first
molar. The expression of activated caspase-8 displayed a gradient,
copying the differentiation pattern of these cells (Schmitt and
Ruch, 2000). Expression of both caspases was cytoplasmic and
did not overlap with apoptosis, suggesting non-apoptotic roles
during development. The expression of caspases-7 and -8 in
epithelial-derived tissue suggests a novel role of these two
caspases in ameloblasts development.
In the bone at the prenatal stage and later in the
perinatal period, caspase-3 was localised mostly in non-
apoptotic osteoclasts and a few osteoblasts, agreeing with
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FIGURE 6 | Caspase engagement in differentiation of osteoblastic cells. Activation of caspases in MC3T3-E1 culture after 21 days of osteoblastic differentiation:
caspase-3 (A),−6 (B),−7 (C),−8 (D),−9 (E), expression of osteocalcin (F), decrease in osteocalcin expression to 74 % after 5 days of caspase inhibition (G),
decrease in osteocalcin expression to 46 % after 6 days of caspase inhibition (H). Expression of osteocalcin detected at the protein level (J) compared with control
samples (I), showing loss of cytoplasmic osteocalcin. Ocn (osteocalcin). *p ≤ 0.05, **p ≤ 0.01.
previous detection in human tissue; however, apoptotic/non-
apoptotic correlation was not performed (Krajewska et al.,
1997). Active caspase-7, again, had a wider expression pattern
compared to caspase-3, and was identified in non-apoptotic
osteoblasts, osteocytes, lining cells, and osteoclasts. Caspase-6
was also apparent in osteoblasts and osteoclasts, but decreased in
perinatal osteoblasts. This change could be explained by declining
age-specific activation observed in other tissues (Godefroy et al.,
Frontiers in Physiology | www.frontiersin.org 10 March 2018 | Volume 9 | Article 174
Svandova et al. Caspases in Tooth and Bone Formation
2013) and suggests a distinct role of caspase-6 in developing
osteoblasts. Notably, all three executioner caspases were localised
in the cytoplasm of non-apoptotic cells in the bone, in contrast
to their nuclear expression in the PEK. Subcellular localisation
of pro-apoptotic caspases was proposed as one option for the
diversification between apoptotic and non-apoptotic functions
(Faleiro and Lazebnik, 2000; Fischer et al., 2003; Kamada et al.,
2005).
Caspase-9, had not previously been studied in the
intramembranous bone in vivo. Nevertheless, caspase-9
was demonstrated in vitro to be activated in the case of BMP-2
mediated apoptosis in primary human calvaria osteoblasts
and in immortalised human calvaria osteoblasts (Haÿ et al.,
2001). Localisation of caspase-9 in the mandibular/alveolar bone
was associated with pre-osteoblastic differentiation and with
osteoclasts.
Activation of caspase-8 was apparent in some apoptotic
cells, which is in accordance with previously published
findings showing caspase-8 activated in apoptotic osteoblasts
or osteocytes in vitro (Kogianni et al., 2004; Goga et al., 2006;
Aoyama et al., 2012; Thaler et al., 2016). Nevertheless, in
the mandibular bone activation of caspase-8 was particularly
associated with non-apoptotic osteoblastic cells (pre-osteoblasts,
osteoblasts, osteocytes, and lining cells) and osteoclasts. The
finding in osteoblastic cells is supported by earlier observations in
vitro, where activation of caspase-8 was associated with osteoblast
differentiation (Mogi and Togari, 2003). Regarding osteoclasts,
these cells are derived from the monocyte macrophage lineage
and, thus, appearance of active caspase-8 may be related to
its role in monocyte differentiation (Kang et al., 2004). Non-
apoptotic function of caspase-8 in myeloid cells was suggested to
act via modification of nuclear factor-kappa B signalling (Solier
et al., 2017), which might also be the case in osteoclasts. The
mechanism of non-apoptotic stimulation of caspase-8 has not yet
been clarified, but one of the proposals is functional divergence
based on altered substrate specificity (Pop et al., 2011).
Substrate specificity of caspases determined by post-
translational modifications and interactions with other proteins
is often suggested as a mechanism for non-apoptotic function
of pro-apoptotic caspases (Zermati et al., 2001; Sordet et al.,
2002; Nhan et al., 2006; Shalini et al., 2015). Caspases, in general,
target hundreds of substrates including not only direct regulators
of apoptosis but also molecules participating in cell adhesion,
cytoskeleton formation, nuclear structural proteins, ER and
Golgi associated proteins, cell cycle regulators, proteins related
to DNA synthesis, cleavage and repair, transcription factors,
molecules associated with RNA synthesis and protein translation
as well as cytokines, membrane receptors, and others (Fischer
et al., 2003; Shalini et al., 2015). Determination of the exact
pathways associated to the non-apoptotic activity of caspases in
odontogenesis and related osteogenesis, such as modulation of
osteocalcin expression, remains to be clarified.
Our investigation provided a comprehensive analysis of pro-
apoptotic caspase activation in different cell types related to
their apoptotic and non-apoptotic status during odontogenesis
and intramembranous osteogenesis. The activation patterns of
caspase-8 and caspase-6 in developing teeth and alveolar bone
are reported here for the first time as well as the non-apoptotic
presence of caspase-9. Additionally, the significant and not yet
known impact of caspase inhibition on osteocalcin expression has
been demonstrated.
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Figure S1 | Activation of caspases in osteoblastic cells detected in
mandibular/alveolar bone. Morphology (haematoxylin-eosin) of mandibular bone at
E13 (A), activation of caspase-8 in pre-osteoblastic cells at E13 (B), activation of
caspase-9 in pre-osteoblastic/osteoblastic cells at E13 (C), morphology
(haematoxylin-eosin) of mandibular/alveolar bone at E15 (D), activation of
caspase-6 in osteoblasts at E15 (E), correlated with localisation of
osteocalcin-positive cells at E15 (F), activation of caspase-7 in osteoblasts at E15
(G), correlated with osteocalcin-positive cells at E15 (H), activation of caspase-7
in lining cells at E15 (I), correlated with osteocalcin-negative cells at E15 (J),
activation of caspase-8 in osteoblasts/lining cells at E15 (K), correlated with
osteocalcin-positive/osteocalcin-negative cells at E15 (L), morphology
(haematoxylin-eosin) of mandibular/alveolar bone at P22 (M), activation of
caspase-7 in matrix incorporated osteocytes at P22 (N), activation of caspase-8
in matrix incorporated osteocytes at P22 (O). Mc (Meckel’s cartilage), mb
(mandibular bone). White arrows point to positive cells, yellow arrows point to
negative.
Figure S2 | Activation of caspases in odontoblastic cells detected in the first
molar of mandible. Morphology (haematoxylin-eosin) of the first molar at
stage E18 (A) and pre-dentin detection (arrow) by trichrome (A1), activation
of caspase-7 in pre-odontoblasts—future crown segment (pronounced
differentiation) at E18 (B), activation of caspase-7 in pre-odontoblasts—future
root segment (retarded differentiation) at E18 (C), activation of caspase-8 in
pre-odontoblasts—future crown segment at E18 (D), activation of caspase-8
in pre-odontoblasts—future root segment at E18 (E), morphology
(haematoxylin-eosin) of the first molar at stage P22 (F) activation of
caspase-7 in odontoblasts—crown segment (pronounced differentiation) at
P22 (G), activation of caspase-7 in odontoblasts—root segment (retarded
differentiation) at P22 (H), activation of caspase-8 in odontoblasts—crown
segment at P22 (I), activation of caspase-8 in odontoblasts—root segment
at P22 (J). Ab, alveolar bone; am, ameloblasts; dp, dental pulp; mb,
mandibular bone; od, odontoblasts. Arrows point to positive cells.
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